Volume 32, Number 1—January 2026
Synopsis
Case Series of Bacteremia Associated with Probiotic Use in Children after Cardiac Surgery, China
Table 1
Demographic characteristics and surgical parameters of 6 patients in study of bacteremia associated with probiotic use in children after cardiac surgery*
| Category | Patient number |
|||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| Age/sex |
6 y/F |
8 mo/M |
8 mo/M |
1.5 y/M |
9 mo/F |
13 y/F |
| Body weight, kg |
21.5 |
5.4 |
5.1 |
11 |
7.2 |
57 |
| Height, cm |
111 |
63 |
62 |
85 |
70 |
150 |
| SpO2, % |
80 |
86 |
92 |
91 |
100 |
78 |
| Cardiac disease |
Single ventricle |
Swiss-cheese VSD |
PAA/TECD/MAPCAs |
mL-TGA; TR |
Dilated cardiomyopathy |
DORV; complications of previous Glenn procedure; TR |
| Cardiac procedure |
Fontan |
PA-banding |
RV-PA connection |
DSO; tricuspid valvuloplasty |
PA-banding |
Tricuspid valve replacement |
| Palliative surgery |
Yes |
Yes |
Yes |
No |
Yes |
Yes |
| Residual deformities |
Pulmonary hypertension |
Increased pulmonary blood flow |
Pulmonary dysplasia; MAPCAs |
Cardiac dysfunction |
Cardiac dysfunction |
COVID-19; pulmonary embolism |
| Maximum VIS |
29 |
9 |
14 |
26 |
8 |
11 |
| Vasopressin use |
Yes |
No |
Yes |
Yes |
No |
Yes |
| Maximum CVP, mm Hg | 19 | 4 | 9 | 13 | 8 | 12 |
*Patient 6 died of severe cardiac disease, not attributable to probiotic use. CVP, central venous pressure; DORV, double outlet right ventricle; DSO, double switch operation; MAPCAs, major aortopulmonary collateral arteries; mL-TGA, congenitally corrected transposition of the great arteries; PAA, pulmonary artery atresia; PA, pulmonary artery; RV, right ventricle; TECD, total endocardial cushion defect; TR, tricuspid regurgitation; VIS, vasoactive inotropic score; VSD, ventricular septal defect.
1These authors contributed equally to this article.
Page created: December 13, 2025
Page updated: January 27, 2026
Page reviewed: January 27, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.